TrialBritish journal of cancer2013

Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer.

C Pezaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.